152 related articles for article (PubMed ID: 36152761)
1. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
Sun L; Feng H; Misumi I; Shirasaki T; Hensley L; González-López O; Shiota I; Chou WC; Ting JP; Cullen JM; Cowley DO; Whitmire JK; Lemon SM
J Hepatol; 2023 Feb; 78(2):271-280. PubMed ID: 36152761
[TBL] [Abstract][Full Text] [Related]
2. Hepatovirus 3ABC proteases and evolution of mitochondrial antiviral signaling protein (MAVS).
Feng H; Sander AL; Moreira-Soto A; Yamane D; Drexler JF; Lemon SM
J Hepatol; 2019 Jul; 71(1):25-34. PubMed ID: 30876947
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
Colasanti O; Burm R; Huang HE; Riedl T; Traut J; Gillich N; Li TF; Corneillie L; Faure-Dupuy S; Grünvogel O; Heide D; Lee JY; Tran CS; Merle U; Chironna M; Vondran FFW; Esser-Nobis K; Binder M; Bartenschlager R; Heikenwälder M; Meuleman P; Lohmann V
J Hepatol; 2023 Sep; 79(3):645-656. PubMed ID: 37121436
[TBL] [Abstract][Full Text] [Related]
4. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
[TBL] [Abstract][Full Text] [Related]
5. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
[TBL] [Abstract][Full Text] [Related]
6. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
Yang Y; Liang Y; Qu L; Chen Z; Yi M; Li K; Lemon SM
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7253-8. PubMed ID: 17438296
[TBL] [Abstract][Full Text] [Related]
7. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
[TBL] [Abstract][Full Text] [Related]
8. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
9. Control of hepatitis C virus replication in mouse liver-derived cells by MAVS-dependent production of type I and type III interferons.
Anggakusuma ; Frentzen A; Gürlevik E; Yuan Q; Steinmann E; Ott M; Staeheli P; Schmid-Burgk J; Schmidt T; Hornung V; Kuehnel F; Pietschmann T
J Virol; 2015 Apr; 89(7):3833-45. PubMed ID: 25609814
[TBL] [Abstract][Full Text] [Related]
10. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
12. MAVS-dependent host species range and pathogenicity of human hepatitis A virus.
Hirai-Yuki A; Hensley L; McGivern DR; González-López O; Das A; Feng H; Sun L; Wilson JE; Hu F; Feng Z; Lovell W; Misumi I; Ting JP; Montgomery S; Cullen J; Whitmire JK; Lemon SM
Science; 2016 Sep; 353(6307):1541-1545. PubMed ID: 27633528
[TBL] [Abstract][Full Text] [Related]
13. Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected
Misumi I; Li Z; Sun L; Das A; Shiota T; Cullen J; Zhang Q; Whitmire JK; Lemon SM
J Virol; 2021 May; 95(11):e0005821. PubMed ID: 33692213
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
Qu L; Lemon SM
Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in
Shiota T; Matsuda M; Zheng X; Nagata N; Ishii K; Suzuki R; Muramatsu M; Takimoto K; Hanaki KI; Lemon SM; McGivern DR; Hirai-Yuki A
J Virol; 2022 Dec; 96(23):e0149622. PubMed ID: 36354341
[TBL] [Abstract][Full Text] [Related]
16. Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.
Kusov Y; Gauss-Müller V
J Virol; 1999 Dec; 73(12):9867-78. PubMed ID: 10559299
[TBL] [Abstract][Full Text] [Related]
17. IRF3-mediated pathogenicity in a murine model of human hepatitis A.
Sun L; Li Y; Misumi I; González-López O; Hensley L; Cullen JM; McGivern DR; Matsuda M; Suzuki R; Sen GC; Hirai-Yuki A; Whitmire JK; Lemon SM
PLoS Pathog; 2021 Sep; 17(9):e1009960. PubMed ID: 34591933
[TBL] [Abstract][Full Text] [Related]
18. Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA.
Lanford RE; Feng Z; Chavez D; Guerra B; Brasky KM; Zhou Y; Yamane D; Perelson AS; Walker CM; Lemon SM
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11223-8. PubMed ID: 21690403
[TBL] [Abstract][Full Text] [Related]
19. Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
Bender S; Reuter A; Eberle F; Einhorn E; Binder M; Bartenschlager R
PLoS Pathog; 2015 Nov; 11(11):e1005264. PubMed ID: 26588843
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of host proteins by the Group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus.
Morazzani EM; Compton JR; Leary DH; Berry AV; Hu X; Marugan JJ; Glass PJ; Legler PM
Antiviral Res; 2019 Apr; 164():106-122. PubMed ID: 30742841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
